Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli

• Status: Unknown status
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

In patients with documented ESBL-producing E.coli and Klebsiella pneumoniae will be allocated to receive colistin or conventional antibiotic regimen.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mahidol University
• Treatments: Colistin

Criteria

Inclusion Criteria:

• Age > 18 yr.

• Hospitalized to Siriraj Hospital

• Infections with ESBL-producing E.coli or K.pneumoniae

• Consent informed consent

Exclusion Criteria:

• Pregnancy or lactating mother

• Colistin allergy

• Neurologic diseases